Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
Benndorf RA, Schwedhelm E, Gnann A, Taheri R, Kom G, Didié M, Steenpass A, Ergün S, Böger RH. Benndorf RA, et al. Among authors: didie m. Circ Res. 2008 Oct 24;103(9):1037-46. doi: 10.1161/CIRCRESAHA.108.184036. Epub 2008 Sep 18. Circ Res. 2008. PMID: 18802021
Impact of AT2 receptor deficiency on postnatal cardiovascular development.
Biermann D, Heilmann A, Didié M, Schlossarek S, Wahab A, Grimm M, Römer M, Reichenspurner H, Sultan KR, Steenpass A, Ergün S, Donzelli S, Carrier L, Ehmke H, Zimmermann WH, Hein L, Böger RH, Benndorf RA. Biermann D, et al. Among authors: didie m. PLoS One. 2012;7(10):e47916. doi: 10.1371/journal.pone.0047916. Epub 2012 Oct 29. PLoS One. 2012. PMID: 23144713 Free PMC article.
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.
Rudolph V, Andrié RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K, Sydow K, Didié M, Seniuk A, von Leitner EC, Szoecs K, Schrickel JW, Treede H, Wenzel U, Lewalter T, Nickenig G, Zimmermann WH, Meinertz T, Böger RH, Reichenspurner H, Freeman BA, Eschenhagen T, Ehmke H, Hazen SL, Willems S, Baldus S. Rudolph V, et al. Among authors: didie m. Nat Med. 2010 Apr;16(4):470-4. doi: 10.1038/nm.2124. Epub 2010 Mar 21. Nat Med. 2010. PMID: 20305660 Free PMC article.
Tissue engineering of a differentiated cardiac muscle construct.
Zimmermann WH, Schneiderbanger K, Schubert P, Didié M, Münzel F, Heubach JF, Kostin S, Neuhuber WL, Eschenhagen T. Zimmermann WH, et al. Among authors: didie m. Circ Res. 2002 Feb 8;90(2):223-30. doi: 10.1161/hh0202.103644. Circ Res. 2002. PMID: 11834716
Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue.
Tiburcy M, Didié M, Boy O, Christalla P, Döker S, Naito H, Karikkineth BC, El-Armouche A, Grimm M, Nose M, Eschenhagen T, Zieseniss A, Katschinksi DM, Hamdani N, Linke WA, Yin X, Mayr M, Zimmermann WH. Tiburcy M, et al. Among authors: didie m. Circ Res. 2011 Oct 28;109(10):1105-14. doi: 10.1161/CIRCRESAHA.111.251843. Epub 2011 Sep 15. Circ Res. 2011. PMID: 21921264 Free article.
Heart muscle engineering: an update on cardiac muscle replacement therapy.
Zimmermann WH, Didié M, Döker S, Melnychenko I, Naito H, Rogge C, Tiburcy M, Eschenhagen T. Zimmermann WH, et al. Among authors: didie m. Cardiovasc Res. 2006 Aug 1;71(3):419-29. doi: 10.1016/j.cardiores.2006.03.023. Epub 2006 Apr 7. Cardiovasc Res. 2006. PMID: 16697358 Review.
43 results